Abstract
Behçet’s Disease (BD) is a multisystemic inflammatory disorder as a triad of symptoms including recurrent oral and genital aphthous ulceration, and uveitis with unknown pathogenesis. Many researchers have tried to investigate the association of HLA-B51 gene with the BD. We aimed to investigate the association of the HLA-B51 gene and its expression, also polymorphic structure by PCR, RT-PCR and sequence specific oligonucleotide primers and probes in BD patients (n: 35) and control group (n: 50). According to our results, we did not observe any association in between HLA-B51 gene, its polymorphism, expression and BD patients.
Similar content being viewed by others
References
Dilşen N (1996) History and development of Behçet’s disease. Rev Rhum 63:512–519
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. New Engl J Med 341:1284–1291
Schirmer M, Calamia KT, Direskeneli H (2001) Workshop report: ninth international conference on Behçet’s disease, Seoul, Korea, May 27–29, 2000. J Rheumatol 28:636–639
Choukri F, Chakib A, Himmich H et al (2001) HLA-B*51 and B*15 alleles confer predisposition to Behçet’s disease in Moroccan patients. Hum Immunol 62:180–185
Direskeneli H (2001) Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002
Emmi L, Brugnolo F, Salvati G et al (1995) Immunopathological aspects of Behçet’s disease. Clin Exp Rheumatol 13:687–691
Mizuki N, Ota M, Kimura M et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behçet’s disease. Proc Natl Acad Sci 94:1298–1303
Wallace GR, Verity DH, Delamaine LJ et al (1999) MIC-A allele profiles and HLA class I associations in Behçet’s disease. Immunogenetics 49:613–617
Zierhut M, Mizuki N, Ohno S et al (2003) Human genome and disease: Review. Immunology and functional genomics of Behçet’s disease. Cell Mol Life Sci 60:1903–1922
Zouboulis CC (1999) Epidemiology of Adamantiates-Behçet’s disease. Ann Med Interne 150:488–498
van den Elsen PJ, Gobin SJP, van Eggermond MCAJ et al (1998) Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48:208–221
Kostyu DD, Hannick LI, Traweek JL et al (1997) HLA class I polymorphism: Structure and function and still questions. Hum Immunol 57:1–18
Middleton D, Curran M, Maxwell L (2002) Natural killer cells and their receptors. Transpl Immunol 10:147–164
Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201–212
Lanier LL (1997): Natural killer cell receptors and MHC class I interactions. Curr Opin Immunol 9:126–131
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis Behçet’s Disease. Lancet 335:1078–1080
Kera J, Mizuki N, Ota M et al (1999) Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet’s disease in Italian patients. Tissue Antigens 54:565–571
Kötter I, Günaydın I, Stübiger N et al (2001) Comparative analysis of the association of HLA-B*51 suballeles with Behçet’s disease in patients of German and Turkish origin. Tissue Antigens 58:166–170
Mizuki N, Ohno S, Ando H et al (1997) A strong association between HLA-B*5101 and Behçet’s disease in Greek patients. Tissue Antigens 50:57–60
Gül A, Uyar FA, İnanç M (2002) A weak association of HLA-B*2702 with Behçet’s disease. Genes Immun 3:368–372
Ahmad T, Wallace GR, James T et al (2003) Mapping the HLA association in Behçet’s disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813
Sano K, Yabuki K, Imagawa Y et al (2001) The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet’s disease. Tissue Antigens 58:77–82
Verity DH, Marr JE, Ohno S et al (1999) Behçet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213–220
Verity DH, Wallace GR, Vaughan RW et al (2003) Behçet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175–1183
Cohen R, Metzger S, Nahir M et al (2002) Association of the MIC-A gene and HLA-B51 with Behçet’s disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 61:157–160
Gonzales-Escaribano MF, Rodriguez MR, Aguilar F et al (1999) Lack of association of MICA transmembrane region polymorphism and Behçet’s disease in Spain. Tissue Antigens 54:278–281
İkbal M, Atasoy M, Pirim İ et al (2006) The alteration of sister chromatid exchange frequencies in Behçet’s disease with and without HLA-B51. JEADV 20:149–152
Itoh Y, Inoko H, Kulski JK et al (2006) Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behçet’s disease by a PCR-SSOP-Luminex method. Tissue Antigens 67:390–394
Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic disease with vasculitis. Ann Rheum Dis 62:1083–1087
Mizuki N, Yabuki K, Ota M et al (2002) Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet’s disease. Tissue Antigens 60:396–399
Paul M, Klein T, Krause I et al (2001) Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet’s disease. Tissue Antigens 58:185–186
Pirim I, Atasoy M, İkbal M et al (2004) HLA class I and class II genotyping in patients with Behçet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297
Coşkun M, Babacanlı A, Sallakçı N et al (2005) Specific Interleukine-1 gene polymorphisms in Turkish patients with Behçet’s disease. Exp Dermatol 14:124–129
Saruhan-Direskeneli G, Uyar FA, Çefle A et al (2004) Expression of KIR and C-type lectin teceptors in Behçet’s disease. Rheumatology 43:423–427
Soto-Vega E, Garcia-Munoz R, Richaud-Patin Y et al (2004) Class I and class II MHC polymorphisms in Mexican patients with Behçet’s disease. Immunol Lett 93:211–215
Direskeneli H, Ekşioğlu-Demiralp E, Kibaroğlu A et al (1999) Oligoclonal T cell expansions in patients with Behçet’s disease. Clin Exp Immunol 117:166–170
Ekşioğlu-Demiralp E, Direskeneli H, Ergün T (1999) Increased CD4+ CD16+ nd CD4+ CD56+ T cell subsets in Behçet’s disease. Rheumatol Int 19:23–26
Acknowledgements
Authors are thankful to Dr Soner Akpinar from Opthalmology Department for his valuable effort in the identification of BD patients. This study was supported by Pamukkale University Research Fund (Project No. 2001TPF020), TÜBİTAK (Scientific and Research Council of Turkey, Project No. SBAG 2388) and Turkish Government State Planning Department Project (Project No.2001K121120). DNA bank was constructed in the framework the TUBİTAK Project No.SBAG-2388.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atalay, A., Yıldız-Demirtepe, S., Tatlıpınar, S. et al. HLA-B51 gene and its expression in association with Behçet’s Disease in Denizli Province of Turkey. Mol Biol Rep 35, 345–349 (2008). https://doi.org/10.1007/s11033-007-9092-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-007-9092-4